Pediatric coccidioidomycosis in central California: a retrospective case series

James M McCarty1, Lindsey C Demetral, Lukasz Dabrowski

  • 1Department of Pediatrics, Children's Hospital Central California, Madera, CA 93638, USA. jmccarty@childrenscentralcal.org

Insights

Coccidioidomycosis is a significant fungal infection in children in central California, often causing severe illness like mediastinitis. This condition, along with high antibody titers, leads to prolonged hospital stays, highlighting the need for better treatments.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Mycology

Background:

  • Coccidioidomycosis is an endemic fungal infection prevalent in the southwestern United States.
  • Pediatric cases of coccidioidomycosis are not extensively documented in medical literature.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of children hospitalized with coccidioidomycosis.
  • To identify factors associated with severe disease and prolonged hospitalization in pediatric patients.

Main Methods:

  • A retrospective observational study was conducted.
  • Data were collected from children admitted to Children's Hospital Central California between January 1, 2010, and September 1, 2011.
  • Included were demographic, clinical, and laboratory data.

Main Results:

  • Thirty-three children (6 months to 17 years) were hospitalized.
  • Common manifestations included pneumonia, pleural effusion, and lung abscess.
  • Mediastinitis occurred in 21% of patients, more frequently in younger children, and was associated with significantly longer hospitalizations (median 130 days).
  • Higher coccidioidal complement fixation antibody titers (≥1:128) also correlated with extended hospital stays (median 174 days).
  • One patient died due to meningitis.

Conclusions:

  • Coccidioidomycosis imposes a considerable disease burden on children in central California.
  • Mediastinitis is a frequent complication in pediatric coccidioidomycosis, particularly in younger children.
  • Longer hospitalizations are associated with mediastinitis and elevated antibody titers, underscoring the need for targeted interventions and further research into prevention and treatment strategies.
Abstract

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...